spacer

About NIDA SBIR/STTR Programs

The National Institute on Drug Abuse (NIDA) is the Federal Government's lead agency for supporting scientific research on drug abuse and addiction. NIDA is one of the National Institutes of Health (NIH) in the U.S. Department of Health and Human Services. NIDA's mission is to lead the Nation in bringing the power of science to bear on drug abuse and addiction. NIDA-supported scientific research addresses the most fundamental and essential questions about drug abuse, which range from the molecule to managed care and from DNA to community outreach research.

NIDA, as part of the NIH, is required by statute (SBIR/STTR Reauthorization Act of 2011, P.L. 112-81) to reserve a portion of its annual extramural budget for projects under the SBIR and STTR programs. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are one of the largest sources of early-stage capital for innovative small companies in the United States. These programs allow US-owned and operated small businesses to engage in federal research and development (R&D) that has a strong potential for commercialization (link).

In January 2015, NIDA published NOT-DA-15-041 describing the current priorities for NIDA SBIR and STTR Programs. NIDA will accept very strong applications outside of the areas of current strategic interest for funding at the levels of statutory guidelines.

Scientific research relevant to NIDA's mission including SBIR and STTR projects is overseen by various NIDA Divisions whose scientific expertise ranges from neurobiological and behavioral mechanisms of drugs of abuse and the consequences of drug use to the service and prevention research. Before submitting their applications, SBIR and STTR potential applicants are strongly encouraged to discuss their research proposals with the appropriate Division SBIR and STTR Representatives. Below is a list of NIDA Divisions and contact information for Division SBIR and STTR Representatives. For budget related questions, please contact the Grants Management Branch (GMB). Click on each to learn about NIDA Divisions:

Division of Neuroscience and Behavior (DNB) ""
Kris Bough, PhD
Program Director
Tel: 301.443.9800
Boughk@mail.nih.gov

Division of Therapeutics and Medical Consequences (DTMC) ""
Aidan Hampson, PhD
Program Officer
Tel: 301.827.5925
Aidan.hampson@nih.gov

Division of Epidemiology, Services and Prevention Research (DESPR) ""
David Thomas, PhD
Health Scientist Administrator
Tel: 301.435.1313
Dthomas1@nida.nih.gov

Center for Clinical Trials (CCTN) ""
Quandra Scudder
Scientific Program Analyst
Tel: 301.480.2516
SBudderq@nida.nih.gov

Office of Acquisition (OA)
Andrew R. Hotaling 
Contracting Officer
Tel: 301.443.6677
Hotalingar@mail.nih.gov

Grants Management Branch (GMB)
Amy Connolly 
Grants Management Specialist
Tel: 301.827.4457
Connolla@nida.nih.gov